Logo
COVID-19: Pharmidex Contingency Plan
March 19, 2020

Pharmidex are taking all the necessary steps to ensure the progression of client studies during these difficult time.

COVID-19: Pharmidex Contingency Plan


We are taking all necessary steps to ensure that studies proceed, while preserving the health and safety of staff. Summary of key steps taken at Pharmidex:


- Following the relevant guidelines issued by Public Health England.


- Limiting access to only essential people in our laboratories and cancelling/rescheduling all non-critical visitors. All visitors must confirm COVID-19 status prior to arrival.


- Cancelled all non-essential business travel.


- Closely communicating with suppliers regarding the status of their inventories and their business continuity plans and identifying alternate sources for supplies.


- Implemented strict sanitization practices to prevent cross contamination between staff, including providing our staff with resources and up-to-date information and guidance.


- To prevent the potential spread of the infection amongst employees, staff will declare any potential close contact with infected individuals and follow the relevant health guidelines.


- Our operations team will ensure adequate staffing cover so as not to compromise client studies.


We will keep you updated if the situation changes resulting in any impact on progression of your projects.


Best wishes to everyone during these tough times.

February 18, 2025
We’re thrilled to offer Haematology Services to advance drug development and research. Our lab features, the Siemens analyser, delivering precise results across key biological parameters. 🔬 Services Include: Full Blood Count (FBC) Reticulocytes Differential Analysis 🐾 Supporting human and animal models 💡 Applications: Diagnose blood disorders (anaemia, leukaemia and others). Evaluate treatment efficacy in preclinical models. Translate findings from animals to humans. 📦 Sample Details: Minimum 200 µL of EDTA whole blood. Reach out today to learn how we can support your research!
February 13, 2025
We had great fun networking, supporting wellbeing, nurturing our community and raising money for Stevenage based STEMPOINT , the educational charity dedicated to widening access into science, engineering, maths and technology subjects across EastAnglia. Over 30 players took part in the cross-campus sports event, we welcomed teams from GSK, ImmuONE, Tessellate BIO, Neobe Therapeutics, Stevenage Bioscience Catalyst, Pharmidex , MFX, Antikor Biopharma Ltd – and of course STEMPOINT - who came to join us. Congratulations goes to Ash Alavijeh from Pharmidex who won best player of the rally! See you all again in the next badminton tournament in the Spring!
OBN Science Social
February 12, 2025
Pharmidex at OBN Science Social
More Posts
Share by: